HC
GILD icon

Henshaw Capital’s Gilead Sciences GILD Stock Holding History

Henshaw Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,354
Closed -$379K – 287
2017
Q2 		$379K Hold
5,354
– – 0.04% 187
2017
Q1 		$364K Hold
5,354
– – 0.04% 188
2016
Q4 		$383K Hold
5,354
– – 0.05% 167
2016
Q3 		$424K Buy
5,354
+2,025
+61% +$164K 0.05% 140
2016
Q2 		$278K Hold
3,329
– – 0.04% 202
2016
Q1 		$306K Buy
+3,329
New +$300K 0.04% 186

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Henshaw Capital's GILD Position: Q3 2017 in Review

Henshaw Capital sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 5,354 shares — an estimated $379K sold.

Henshaw Capital first reported a position in GILD in Q1 2016 and held it in 6 quarters. The position peaked at $424K in Q3 2016. 1,505 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Henshaw Capital reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Henshaw Capital sold 5,354 Gilead Sciences shares in Q3 2017, an estimated $379K.
  • Henshaw Capital first reported a position in Gilead Sciences in Q1 2016 and held it in 6 quarters.
  • Henshaw Capital's Gilead Sciences position peaked at $424K in Q3 2016.
  • 1,505 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Henshaw Capital's 13F filing for Q3 2017, filed 28 May 2026.